EA199900046A3 - Таблетки, седержащие мезилат тровафлоксацина - Google Patents

Таблетки, седержащие мезилат тровафлоксацина

Info

Publication number
EA199900046A3
EA199900046A3 EA199900046A EA199900046A EA199900046A3 EA 199900046 A3 EA199900046 A3 EA 199900046A3 EA 199900046 A EA199900046 A EA 199900046A EA 199900046 A EA199900046 A EA 199900046A EA 199900046 A3 EA199900046 A3 EA 199900046A3
Authority
EA
Eurasian Patent Office
Prior art keywords
variants
composition
trovafloxacin mesylate
trovafloxacin
mesylate
Prior art date
Application number
EA199900046A
Other languages
English (en)
Other versions
EA003247B1 (ru
EA199900046A2 (ru
Inventor
Элтон Дейл Джонсон
Кристофер Майкл Синко
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900046A2 publication Critical patent/EA199900046A2/ru
Publication of EA199900046A3 publication Critical patent/EA199900046A3/ru
Publication of EA003247B1 publication Critical patent/EA003247B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA199900046A 1998-01-21 1999-01-21 Композиция, содержащая мезилат тровафлоксацина (варианты) EA003247B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (3)

Publication Number Publication Date
EA199900046A2 EA199900046A2 (ru) 1999-08-26
EA199900046A3 true EA199900046A3 (ru) 1999-12-29
EA003247B1 EA003247B1 (ru) 2003-02-27

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900046A EA003247B1 (ru) 1998-01-21 1999-01-21 Композиция, содержащая мезилат тровафлоксацина (варианты)

Country Status (34)

Country Link
US (1) US6187341B1 (ru)
EP (1) EP0930068A3 (ru)
JP (1) JPH11269072A (ru)
KR (1) KR100314977B1 (ru)
CN (1) CN1227743A (ru)
AP (1) AP1094A (ru)
AR (1) AR012780A1 (ru)
AU (1) AU758381B2 (ru)
BG (1) BG103106A (ru)
BR (1) BR9900116A (ru)
CA (1) CA2259698C (ru)
CO (1) CO4810225A1 (ru)
DZ (1) DZ2712A1 (ru)
EA (1) EA003247B1 (ru)
GT (1) GT199900004A (ru)
HR (1) HRP990023A2 (ru)
HU (1) HUP9900154A3 (ru)
ID (1) ID23735A (ru)
IL (1) IL128051A0 (ru)
IS (1) IS4947A (ru)
MA (1) MA24747A1 (ru)
NO (1) NO990243L (ru)
NZ (1) NZ333838A (ru)
OA (1) OA10958A (ru)
PA (1) PA8466701A1 (ru)
PE (1) PE20000169A1 (ru)
PL (1) PL330981A1 (ru)
SG (1) SG70666A1 (ru)
SK (1) SK4299A3 (ru)
TN (1) TNSN99007A1 (ru)
TR (1) TR199900089A3 (ru)
TW (1) TW518224B (ru)
YU (1) YU2399A (ru)
ZA (1) ZA99393B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610327B1 (en) * 1998-11-10 2003-08-26 Bayer Aktiengesellschaft Pharmaceutical moxifloxacin preparation
EP1216058A2 (en) * 1999-09-20 2002-06-26 Alza Corporation Process for lessening polymorphic conversion of a drug
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Fabi阻害剤
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
EP1560584B1 (en) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1396263A1 (en) 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ,インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
WO2005009395A2 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
ES2531735T3 (es) * 2004-10-15 2015-03-18 Supernus Pharmaceuticals, Inc. Preparaciones farmacéuticas con menor potencial de abuso
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
EP0930068A2 (en) 1999-07-21
IS4947A (is) 1999-07-22
HUP9900154A3 (en) 2000-12-28
HRP990023A2 (en) 1999-08-31
TR199900089A2 (xx) 1999-10-21
OA10958A (en) 2001-10-31
MA24747A1 (fr) 1999-10-01
YU2399A (sh) 2002-06-19
NO990243L (no) 1999-07-22
EA003247B1 (ru) 2003-02-27
GT199900004A (es) 2000-07-08
BR9900116A (pt) 2000-05-02
AU758381B2 (en) 2003-03-20
KR100314977B1 (ko) 2001-11-24
TR199900089A3 (tr) 1999-10-21
AP9901443A0 (en) 1999-03-31
ID23735A (id) 2000-05-11
EA199900046A2 (ru) 1999-08-26
HU9900154D0 (en) 1999-03-29
PE20000169A1 (es) 2000-03-10
BG103106A (en) 1999-08-31
PL330981A1 (en) 1999-08-02
KR19990068014A (ko) 1999-08-25
TW518224B (en) 2003-01-21
CA2259698C (en) 2003-04-15
CN1227743A (zh) 1999-09-08
IL128051A0 (en) 1999-11-30
ZA99393B (en) 2000-07-21
SK4299A3 (en) 2000-06-12
CO4810225A1 (es) 1999-06-30
HUP9900154A2 (hu) 1999-09-28
US6187341B1 (en) 2001-02-13
NZ333838A (en) 2000-03-27
JPH11269072A (ja) 1999-10-05
DZ2712A1 (fr) 2003-09-01
AR012780A1 (es) 2000-11-08
AU1217399A (en) 1999-08-12
CA2259698A1 (en) 1999-07-21
NO990243D0 (no) 1999-01-20
PA8466701A1 (es) 2000-09-29
SG70666A1 (en) 2000-02-22
EP0930068A3 (en) 1999-12-22
TNSN99007A1 (fr) 2005-11-10
AP1094A (en) 2002-08-19

Similar Documents

Publication Publication Date Title
GC0000108A (en) 4-Amino substituted-2-substituted-1,2,3,4-tetrahy droquinolines.
GC0000068A (en) Catalyst composition.
EG24814A (en) Novel compounds.
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
ZA99454B (en) Novel dosage form.
EA199900046A3 (ru) Таблетки, седержащие мезилат тровафлоксацина
ZA996185B (en) Sulfanylsilanes.
ZA200004956B (en) Vaccine composition.
ZA200005136B (en) Dihydropyrimides.
EP1025858A4 (en) DRUGS WITH REDUCED BITTERNESS ETC.
ZA995673B (en) Fungicidal trifluoromethylalkylamino-triazolopyrimidines.
ZA200005134B (en) Solid, quick dissolving cetirizine formulations.
HK1038884A1 (en) Medicinal compositions.
ZA991272B (en) Novel thiobenzamides.
ZA200005369B (en) Calcilytic compounds.
ZA200005510B (en) Pharmaceutical composition.
ZA99733B (en) Ophthalmic composition.
HK1036280A1 (en) Antivirals.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993197B (en) Pesticidal composition.
ZA991032B (en) Chemical compounds.
MXPA01000464A (es) Composicion.
ZA200006118B (en) Novel composition.
ZA981893B (en) Chemical composition.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU